Global IVD Testing Market Potential Deeply Studied by Kalorama Information

28 Aug 2012 • by Natalie Aster

A large number of acquisitions and partnerships occurred in the in vitro diagnostics industry over the past two years – a sign of the frenetic pace of the industry. There were at least 105 acquisitions and distribution agreements in the IVD market just in the past two years, the majority of which were acquisitions.

According to the recent report “The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition” by Kalorama Information, the activity will continue.

The report cites some examples of acquisitions that have occurred since 2010:

  • Danaher Corporation purchased IVD leader Beckman Coulter 
  • Agilent Technologies purchased FISH/IHC leader Dako 
  • Roche entered a development agreement with Dexcom for its SEVEN PLUS continuous glucose monitor system and purchased the RALS IT connectivity system from Medical Automation Systems 
  • Abbott acquired STARLIMS lab IT system and Biofortuna’s freeze-dried SSPGo HLA typing kits 
  • Terumo Corporation of Japan merged with CaridianBCT a blood unit processing company 
  • Perkin Elmer acquired Caliper Life Sciences 
  • Gen-Probe invested $50 million in Pacific Biosciences, known for its SMRT sequencing platform

Report Details:

The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition
Published: July, 2012
Pages: 1400
Price: US$ 6.500,00

According to the report, a number of totally disparate phenomena have come together for IVD at the same time. Human genome research is finding links between a person’s genome and several lifestyle situations such as nutrition, dieting, skin conditions and other essentially non-medical conditions. This has attracted consumer product companies such as Proctor & Gamble and Nestle to develop products and services based on IVD technologies. Decreases in life science grants have encouraged companies active in this space to migrate their technologies for clinical applications. The result is the entry of companies such as Caliper Life Sciences, Illumina, Affymetrix and Life Technologies to the diagnostics market with products and test services. Miniaturization of traditional immunoassay and molecular test technologies has finally matured to the point where it may be ready for scale-up and then commercialization into products. This has attracted electronics companies such as Sony, Samsung, Dell Computers and Intel to invest in clinical diagnostics ventures. Kalorama Information believes these trends are combining to push growth in the 50+ billion-dollar IVD industry.

“The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition” is Kalorama Information’s complete report on every segment of in vitro diagnostics including clinical chemistry, molecular, point of care, hematology, histology, blood banking, infectious disease and other areas. The report is over 1400 pages and profiles hundreds of companies in the market.

More information can be found in the report “The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition” by Kalorama Information.

To order the report or ask for sample pages contact


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970